gene therapy

Closeup of blue eye on black background
Biotech

4DMT climbs as gene therapy patients keep jettisoning jabs

4DMT posted 60-week data on a gene therapy, providing evidence of durability in DME and sending its stock up more than 40% in premarket trading.
Nick Paul Taylor Aug 1, 2025 5:35am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
FDA
Favicon Fierce Pharma

Vinay Prasad departs FDA amid controversy over gene therapy

Jul 30, 2025 9:33am
FDA
Favicon Fierce Pharma

FDA eyeing study requirements to confirm Elevidys safety: report

Jul 24, 2025 3:12pm
Rocket with heart on blue background

Rocket adjusts trajectory, laying off staff and narrowing focus

Jul 24, 2025 8:05am
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

FDA slaps clinical hold across all of Sarepta’s LGMD trials

Jul 21, 2025 11:36am